Clinical Trial

CT-Angiography Plaque Characteristics and Events in Deferral Patients by Invasive Fractional Flow Reserve

Study acronym: CAPTURE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 3, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Fractional flow reserve (FFR)-guided PCI for chronic coronary syndromes (CCS) is reported to improve the outcomes compared with angiography-guided PCI. However, cardiac-events still occur in FFR-deferral patients in long-term follow-up. Coronary computed tomography angiography (CTA)-defined high-risk-plaque (HRP) is known to relate future cardiac events. The investigators hypothesized that CTA might identify plaque features linked to future cardiac events in deferral patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-14.
Trial Details
NCT Number NCT06508697
Lead Sponsor Fujita Health University
Conditions Patient Preference
Enrollment 400 participants
Start Date 2025-01-30
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-03